Routine

Multiple drug intolerance syndrome

Reactions reported to several unrelated drug classes · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Multiple drug intolerance syndrome is adverse reactions to three or more chemically unrelated drugs without a consistent immunological mechanism, frequently involving subjective symptoms and a background of anxiety. Careful allergy delabelling prevents escalating avoidance that compromises future treatment.

Red flags

  • Objective signs (urticaria, angioedema, hypotension) with any drug
  • Raised baseline tryptase (mast cell disorder)
  • Reaction to a drug essential for a current serious illness
  • Escalating avoidance preventing necessary treatment
  • Features of systemic reaction during challenge

Assessment

Differential diagnosis

  • True multiple drug allergy (immunologically confirmed)
  • Multiple drug intolerance syndrome (non-immune)
  • Underlying mast cell disorder
  • Somatic symptom / anxiety disorder
  • Chronic spontaneous urticaria with drug-attributed flares

Investigations

  • Structured history of each reported reaction, timing and features
  • Review documentation for objective versus subjective reactions
  • Baseline mast cell tryptase to exclude mastocytosis
  • Targeted skin testing / specific IgE for plausible IgE-mediated culprits
  • Supervised drug provocation (challenge) testing where safe to delabel

Management

  • Take a detailed history separating objective reactions from subjective intolerances
  • Identify any reactions with genuine allergic features for formal testing
  • Exclude an underlying mast cell disorder with baseline tryptase
  • Reassure and avoid reinforcing unnecessary labels
  • Perform supervised graded drug provocation to delabel safe drugs
  • Build a documented list of tolerated medications for future use
  • Address coexisting anxiety and provide clear written guidance
  • Refer complex cases to a specialist drug allergy service

Drugs & doses

Cetirizine — 10 mg orally for symptomatic relief during assessment
Adrenaline IM — 500 mcg (0.5 mL 1:1000) available during provocation testing
Chlorphenamine — 10 mg IV/IM for reactions during challenge
Hydrocortisone — 200 mg IV for severe reactions during challenge

Disposition

Outpatient specialist drug allergy assessment with provocation testing; no admission unless a reaction occurs during a monitored challenge.

Complications & pitfalls

  • Avoidance of safe, effective first-line drugs
  • Use of inferior or more toxic alternatives
  • Missed true allergy or mast cell disorder
  • Reinforcement of health anxiety
  • Delay to essential treatment

Exam pearls

  • Most reactions in this syndrome are subjective and non-immune — careful delabelling is key
  • Always exclude an underlying mast cell disorder with baseline tryptase
  • Supervised provocation testing is the most reliable way to restore safe options
  • Document a positive list of tolerated drugs, not just a list of avoidances

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.